PD
ANIP icon

Point72 (DIFC)’s ANI Pharmaceuticals ANIP Stock Holding History

Point72 (DIFC)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$288K Buy
+3,148
New +$257K 0.02% 379

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Point72 (DIFC)'s ANIP Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in ANI Pharmaceuticals (ANIP) in Q3 2025: 3,148 shares worth $288K. The stake represents 0.02% of the portfolio and ranks #379 among its holdings.

269 funds tracked by Wall St. Rank hold ANIP as of Q3 2025.

  • Point72 (DIFC) held 3,148 shares of ANI Pharmaceuticals worth $288K as of Q3 2025.
  • ANI Pharmaceuticals was a new Point72 (DIFC) position in Q3 2025.
  • ANI Pharmaceuticals made up 0.02% of Point72 (DIFC)'s portfolio in Q3 2025, its #379 holding.
  • 269 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.